Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	catalytic activity, acting on RNA	EPRS1 NSUN6 NSUN3 MRPL44 MOV10L1 APEX1 TRMT13 ERN2 TDP2	1.54e-04	417	94	9	GO:0140098
GeneOntologyMolecularFunction	tRNA (cytidine-5-)-methyltransferase activity	NSUN6 NSUN3	2.17e-04	5	94	2	GO:0016428
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	BLM EPRS1 NSUN6 NSUN3 MRPL44 MOV10L1 APEX1 TRMT13 RFC1 ERN2 TDP2	2.23e-04	645	94	11	GO:0140640
GeneOntologyMolecularFunction	protein serine kinase activity	RPS6KA5 PIK3CB MKNK2 MAP3K9 SNRK PRKDC ERN2 MELK	3.16e-04	363	94	8	GO:0106310
GeneOntologyMolecularFunction	tRNA methyltransferase activity	NSUN6 NSUN3 TRMT13	5.44e-04	34	94	3	GO:0008175
GeneOntologyMolecularFunction	ATP-dependent activity	BLM ABCF3 SPG7 CENPE SLC27A1 ATAD2B MOV10L1 RFC1 DNAH5 NLRP3	6.24e-04	614	94	10	GO:0140657
GeneOntologyBiologicalProcess	mitochondrial translational elongation	MRPL44 GFM1 TUFM	8.53e-07	5	92	3	GO:0070125
GeneOntologyBiologicalProcess	tRNA C5-cytosine methylation	NSUN6 NSUN3	1.97e-05	2	92	2	GO:0002946
Domain	ANK	POTEB3 POTED ANKRD11 POTEB2 POTEB POTEC NOTCH3	2.58e-04	251	93	7	SM00248
Domain	ANK_REPEAT	POTEB3 POTED ANKRD11 POTEB2 POTEB POTEC NOTCH3	2.71e-04	253	93	7	PS50088
Domain	ANK_REP_REGION	POTEB3 POTED ANKRD11 POTEB2 POTEB POTEC NOTCH3	2.78e-04	254	93	7	PS50297
Domain	Ankyrin_rpt	POTEB3 POTED ANKRD11 POTEB2 POTEB POTEC NOTCH3	3.35e-04	262	93	7	IPR002110
Domain	NOL1_NOP2_SUN	NSUN6 NSUN3	3.63e-04	6	93	2	PS01153
Domain	RCMT	NSUN6 NSUN3	3.63e-04	6	93	2	IPR023267
Domain	SAM_MT_RSMB_NOP	NSUN6 NSUN3	5.07e-04	7	93	2	PS51686
Domain	MeTrfase_RsmB/NOP2	NSUN6 NSUN3	6.74e-04	8	93	2	IPR001678
Domain	Methyltr_RsmB-F	NSUN6 NSUN3	6.74e-04	8	93	2	PF01189
Domain	AAA	ABCF3 SPG7 ATAD2B RFC1 DNAH5	7.66e-04	144	93	5	SM00382
Domain	AAA+_ATPase	ABCF3 SPG7 ATAD2B RFC1 DNAH5	7.66e-04	144	93	5	IPR003593
Domain	G_TR_CS	GFM1 TUFM	8.63e-04	9	93	2	IPR031157
Domain	P-loop_NTPase	BLM MPP1 ABCF3 SPG7 CENPE ATAD2B MOV10L1 RFC1 GFM1 DNAH5 TUFM NLRP3	1.01e-03	848	93	12	IPR027417
Domain	Ankyrin_rpt-contain_dom	POTEB3 ANKRD11 POTEB2 POTEB POTEC NOTCH3	1.69e-03	254	93	6	IPR020683
Domain	G_TR_1	GFM1 TUFM	1.85e-03	13	93	2	PS00301
Domain	AAA	SPG7 ATAD2B RFC1	2.21e-03	52	93	3	PF00004
Domain	ATPase_AAA_core	SPG7 ATAD2B RFC1	2.47e-03	54	93	3	IPR003959
Domain	PI3/4_kinase_CS	PIK3CB PRKDC	2.47e-03	15	93	2	IPR018936
Domain	-	PIK3CB PRKDC	2.81e-03	16	93	2	1.10.1070.11
Domain	PI3Kc	PIK3CB PRKDC	2.81e-03	16	93	2	SM00146
Domain	-	NSUN6 NSUN3 ASMTL AS3MT	3.05e-03	120	93	4	3.40.50.150
Domain	SAM-dependent_MTases	NSUN6 NSUN3 ASMTL AS3MT	3.23e-03	122	93	4	IPR029063
Domain	PI3_PI4_kinase	PIK3CB PRKDC	3.56e-03	18	93	2	PF00454
Domain	EFTu-like_2	GFM1 TUFM	3.56e-03	18	93	2	IPR004161
Domain	PI3_4_KINASE_1	PIK3CB PRKDC	3.56e-03	18	93	2	PS00915
Domain	PI3_4_KINASE_2	PIK3CB PRKDC	3.56e-03	18	93	2	PS00916
Domain	PI3/4_kinase_cat_dom	PIK3CB PRKDC	3.56e-03	18	93	2	IPR000403
Domain	PI3_4_KINASE_3	PIK3CB PRKDC	3.56e-03	18	93	2	PS50290
Domain	GTP_EFTU_D2	GFM1 TUFM	3.56e-03	18	93	2	PF03144
Domain	G_TR_2	GFM1 TUFM	3.56e-03	18	93	2	PS51722
Domain	-	BLM MPP1 ABCF3 SPG7 ATAD2B MOV10L1 RFC1 GFM1 DNAH5 TUFM	3.96e-03	746	93	10	3.40.50.300
Domain	TF_GTP-bd_dom	GFM1 TUFM	3.97e-03	19	93	2	IPR000795
Domain	UBA-like	UBQLN3 ASCC2 TDP2	4.00e-03	64	93	3	IPR009060
Domain	Apc4_WD40_dom	WRAP73 WDR55	4.40e-03	20	93	2	IPR024977
Domain	ANAPC4_WD40	WRAP73 WDR55	4.40e-03	20	93	2	PF12894
Domain	Ank_2	POTEB3 ANKRD11 POTEB2 POTEC NOTCH3	4.42e-03	215	93	5	PF12796
Domain	Ca/CaM-dep_Ca-dep_prot_Kinase	MKNK2 SNRK MELK	4.94e-03	69	93	3	IPR020636
Pubmed	POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.	POTEB3 POTED POTEB2 POTEB POTEC	7.60e-12	8	95	5	12475935
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	MPP1 EPRS1 DACT1 ZNF605 SPG7 RPS6KA5 PIK3CB MRPL44 DUSP8 APEX1 ROBO2 SEC31A JADE1 RFC1 TDP2 NOTCH3 ZNF71	9.71e-09	1124	95	17	21900206
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NPC1 DACT1 SEPHS2 PWWP2B SPG7 PER2 ANKRD11 SPATA20 PRKDC JADE1 PLEC ZZEF1 GCN1 PLXNA1 MADD KCNH3	5.08e-08	1105	95	16	35748872
Pubmed	Two novel transcripts encoding two Ankyrin repeat containing proteins have preponderant expression during the mouse spermatogenesis.	POTEB2 POTEB POTEC	3.93e-07	6	95	3	17171436
Pubmed	Five POTE paralogs and their splice variants are expressed in human prostate and encode proteins of different lengths.	POTEB3 POTED POTEB	6.86e-07	7	95	3	15276201
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYT1L NPC1 EPRS1 ZNF605 FEZF2 MCF2L2 ADNP2 PRKDC SEC31A PLEC CMYA5 USP9Y TDP2 MADD ZNF292	2.08e-06	1285	95	15	35914814
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	NPC1 GLG1 MRPL44 PLEC DNAH5 TUFM NOTCH3	2.11e-06	214	95	7	22199357
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	EPRS1 MRPL44 KIAA0586 SF3A3 PSMD8 PRKDC SEC31A RFC1 CMYA5 F2 GFM1 DNAH5 GCN1 PLXNA1 TUFM	7.26e-06	1425	95	15	30948266
Pubmed	Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations.	F2 F5	7.38e-06	2	95	2	11836168
Pubmed	Thrombophilic mutations are a main risk factor for placental abruption.	F2 F5	7.38e-06	2	95	2	12857557
Pubmed	Hemiplegic cerebral palsy and the factor V Leiden mutation.	F2 F5	7.38e-06	2	95	2	11183183
Pubmed	Prevalence of factor V Leiden and prothrombin G20210A gene mutation.	F2 F5	7.38e-06	2	95	2	15900364
Pubmed	Risk factors for catheter-related thrombosis in cancer patients.	F2 F5	7.38e-06	2	95	2	15454250
Pubmed	Family history for venous thromboembolism and the risk for recurrence.	F2 F5	7.38e-06	2	95	2	16431184
Pubmed	Prothrombotic gene mutations and Crohn's disease; is there any association?	F2 F5	7.38e-06	2	95	2	16201098
Pubmed	Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study.	F2 F5	7.38e-06	2	95	2	16361766
Pubmed	High incidence of factor V Leiden and prothrombin G20210A in healthy southern Italians.	F2 F5	7.38e-06	2	95	2	19211580
Pubmed	Thrombophilic risk factors in epileptic children treated with valproic Acid.	F2 F5	7.38e-06	2	95	2	19135623
Pubmed	Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency.	F2 F5	7.38e-06	2	95	2	16469858
Pubmed	Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.	F2 F5	7.38e-06	2	95	2	16818854
Pubmed	Are factor V and prothrombin mutations associated with increased risk of oral cancer?	F2 F5	7.38e-06	2	95	2	16080493
Pubmed	Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature.	F2 F5	7.38e-06	2	95	2	22329698
Pubmed	Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.	F2 F5	7.38e-06	2	95	2	33376137
Pubmed	Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis.	F2 F5	7.38e-06	2	95	2	18752569
Pubmed	Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease.	F2 F5	7.38e-06	2	95	2	11741359
Pubmed	Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.	F2 F5	7.38e-06	2	95	2	21659542
Pubmed	Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis.	F2 F5	7.38e-06	2	95	2	18285537
Pubmed	Factor V Leiden and prothrombin G20210A in Portuguese women with recurrent miscarriage: is it worthwhile to investigate?	F2 F5	7.38e-06	2	95	2	21259017
Pubmed	Evaluation of Factor V Leiden and prothrombin G20210A mutations in Sudanese women with severe preeclampsia.	F2 F5	7.38e-06	2	95	2	31501046
Pubmed	Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.	F2 F5	7.38e-06	2	95	2	15947254
Pubmed	Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.	F2 F5	7.38e-06	2	95	2	11694407
Pubmed	[Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].	F2 F5	7.38e-06	2	95	2	16446869
Pubmed	Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis.	F2 F5	7.38e-06	2	95	2	18462012
Pubmed	Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction.	F2 F5	7.38e-06	2	95	2	12725641
Pubmed	Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis.	F2 F5	7.38e-06	2	95	2	19404532
Pubmed	Inherited thrombophilias and unexplained pregnancy loss: an incident case-control study.	F2 F5	7.38e-06	2	95	2	19036071
Pubmed	Factor v leiden mutation in patients with breast cancer with a central venous catheter: risk of deep vein thrombosis.	F2 F5	7.38e-06	2	95	2	18632446
Pubmed	Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis.	F2 F5	7.38e-06	2	95	2	24967675
Pubmed	Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.	F2 F5	7.38e-06	2	95	2	14504875
Pubmed	Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.	F2 F5	7.38e-06	2	95	2	11886391
Pubmed	Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations.	F2 F5	7.38e-06	2	95	2	17439630
Pubmed	Mesenteric vein thrombosis in a patient heterozygous for factor V Leiden and G20210A prothrombin genotypes.	F2 F5	7.38e-06	2	95	2	24282370
Pubmed	Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians.	F2 F5	7.38e-06	2	95	2	19560187
Pubmed	Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis.	F2 F5	7.38e-06	2	95	2	18392325
Pubmed	Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.	F2 F5	7.38e-06	2	95	2	17067362
Pubmed	Sclerotherapy of varicose veins in patients with documented thrombophilia: a prospective controlled randomized study of 105 cases.	F2 F5	7.38e-06	2	95	2	19620700
Pubmed	A whole-blood homogeneous assay for the multiplex detection of the factor V G1691A and the prothrombin G20210A mutations.	F2 F5	7.38e-06	2	95	2	16006096
Pubmed	Potential prevention of thromboembolism by genetic counseling and testing for two common thrombophilia mutations.	F2 F5	7.38e-06	2	95	2	22210734
Pubmed	Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.	F2 F5	7.38e-06	2	95	2	17890946
Pubmed	Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international multicenter cohort study.	F2 F5	7.38e-06	2	95	2	18983482
Pubmed	Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation.	F2 F5	7.38e-06	2	95	2	18983490
Pubmed	Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome.	F2 F5	7.38e-06	2	95	2	12519104
Pubmed	Lack of association between hemorheological alterations and upper-extremity deep vein thrombosis.	F2 F5	7.38e-06	2	95	2	19318721
Pubmed	Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism.	F2 F5	7.38e-06	2	95	2	14652651
Pubmed	Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality.	F2 F5	7.38e-06	2	95	2	20406709
Pubmed	[Venous thromboembolic events in surgery: a role of genetic disorders].	F2 F5	7.38e-06	2	95	2	18368843
Pubmed	Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin.	F2 F5	7.38e-06	2	95	2	15590403
Pubmed	Meta-analysis of factor V Leiden and prothrombin G20210A polymorphism in migraine.	F2 F5	7.38e-06	2	95	2	25158985
Pubmed	Factor V Leiden, prothrombin G20210A, and risk of sudden coronary death in apparently healthy persons.	F2 F5	7.38e-06	2	95	2	12088785
Pubmed	G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale.	F2 F5	7.38e-06	2	95	2	22909823
Pubmed	Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone.	F2 F5	7.38e-06	2	95	2	14531916
Pubmed	Factor VLeiden and prothrombin G20210A gene polymorphisms in patients with coronary artery disease.	F2 F5	7.38e-06	2	95	2	18452260
Pubmed	Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation.	F2 F5	7.38e-06	2	95	2	12413582
Pubmed	Genetic and acquired thrombotic factors in chronic hepatitis C.	F2 F5	7.38e-06	2	95	2	15056097
Pubmed	Absence of factor V Leiden (G1691A) mutation, FII G20210A allele in coronary artery disease in North India.	F2 F5	7.38e-06	2	95	2	14701945
Pubmed	G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease.	F2 F5	7.38e-06	2	95	2	19356951
Pubmed	Factor V Leiden as a risk factor for preterm birth--a population-based nested case-control study.	F2 F5	7.38e-06	2	95	2	20946152
Pubmed	[High-risk factors and clinical pathological analysis in 21 cases of fatal pulmonary embolism].	F2 F5	7.38e-06	2	95	2	20019774
Pubmed	Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke.	F2 F5	7.38e-06	2	95	2	15116266
Pubmed	The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.	F2 F5	7.38e-06	2	95	2	20563311
Pubmed	Thrombophilic polymorphism--a short-term or long-term risk for recurrence?	F2 F5	7.38e-06	2	95	2	18983501
Pubmed	Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer.	F2 F5	7.38e-06	2	95	2	18777205
Pubmed	Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis.	F2 F5	7.38e-06	2	95	2	18983518
Pubmed	Thrombophilic screening in retinal artery occlusion patients.	F2 F5	7.38e-06	2	95	2	19668753
Pubmed	Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.	F2 F5	7.38e-06	2	95	2	20368522
Pubmed	Comparative study between the Light Cycler and the PCR-restriction fragment length polymorphism in detecting factor V Leiden and factor II 20210G>A mutations.	F2 F5	7.38e-06	2	95	2	16563366
Pubmed	Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population.	F2 F5	7.38e-06	2	95	2	19524925
Pubmed	Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study.	F2 F5	7.38e-06	2	95	2	20492466
Pubmed	Homozygous and double heterozygous Factor V Leiden and Factor II G20210A genotypes predispose infants to thromboembolism but are not associated with an increase of foetal loss.	F2 F5	7.38e-06	2	95	2	14515183
Pubmed	Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction.	F2 F5	7.38e-06	2	95	2	15240970
Pubmed	Low prevalence of coagulation F2 and F5 polymorphisms in mothers and children in a large cohort of patients with neonatal arterial ischemic stroke.	F2 F5	7.38e-06	2	95	2	20528875
Pubmed	Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism.	F2 F5	7.38e-06	2	95	2	12749008
Pubmed	Thromboembolism in heart transplantation: role of prothrombin G20210A and factor V Leiden.	F2 F5	7.38e-06	2	95	2	16177630
Pubmed	Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.	F2 F5	7.38e-06	2	95	2	12008938
Pubmed	Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complications.	F2 F5	7.38e-06	2	95	2	20937743
Pubmed	Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.	F2 F5	7.38e-06	2	95	2	14512389
Pubmed	Factor V Leiden and prothrombin 20210G>A [corrected] mutation and paediatric ischaemic stroke: a case-control study and two meta-analyses.	F2 F5	7.38e-06	2	95	2	20337781
Pubmed	Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation.	NPC1 NLRP3	7.38e-06	2	95	2	30054450
Pubmed	The factor V G1691A, factor V H1299R, prothrombin G20210A polymorphisms in children with family history of premature coronary artery disease.	F2 F5	7.38e-06	2	95	2	19609209
Pubmed	A preliminary study on the role of inherited prothrombotic risk factors in Taiwanese patients with sudden sensorineural hearing loss.	F2 F5	7.38e-06	2	95	2	21170721
Pubmed	Lack of association between factor V Leiden and prothrombin G20210A polymorphisms in Tunisian subjects with a history of myocardial infarction.	F2 F5	7.38e-06	2	95	2	22483732
Pubmed	Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.	F2 F5	7.38e-06	2	95	2	12152677
Pubmed	Prevalence of factor V Leiden and G20210A prothrombin mutation in the Dutch Famine Birth Cohort: a possible survival advantage?	F2 F5	7.38e-06	2	95	2	22627863
Pubmed	Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.	F2 F5	7.38e-06	2	95	2	16973976
Pubmed	Multilocus genetic risk scores for venous thromboembolism risk assessment.	F2 F5	7.38e-06	2	95	2	25341889
Pubmed	Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.	F2 F5	7.38e-06	2	95	2	15033664
Pubmed	Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.	F2 F5	7.38e-06	2	95	2	18791166
Pubmed	Prevalence and significance of two major inherited thrombophilias in infective endocarditis.	F2 F5	7.38e-06	2	95	2	25711313
Pubmed	Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale.	F2 F5	7.38e-06	2	95	2	17525392
Pubmed	The influence of the age in the risk of the prothrombin G20210A mutation for spontaneous venous thrombosis.	F2 F5	7.38e-06	2	95	2	17537362
Interaction	POTED interactions	POTEB3 POTED POTEC	4.05e-07	4	95	3	int:POTED
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTED POTEB2 POTEB POTEC	1.13e-07	13	66	4	685
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ADNP2 ZFHX2 TSHZ1	2.05e-05	15	66	3	529
GeneFamily	Ankyrin repeat domain containing	POTED ANKRD11 POTEB2 POTEB POTEC NOTCH3	2.51e-04	242	66	6	403
GeneFamily	NOP2/Sun RNA methyltransferase family	NSUN6 NSUN3	2.72e-04	7	66	2	664
GeneFamily	Mitogen-activated protein kinase-activated protein kinases	RPS6KA5 MKNK2	7.07e-04	11	66	2	1156
GeneFamily	AAA ATPases	SPG7 ATAD2B RFC1	9.55e-04	53	66	3	413
Coexpression	GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP	RAB3GAP1 RPS6KA5 ASMTL KCNQ1 PRKDC PLEC ZZEF1 TUFM	6.88e-07	200	95	8	M5185
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	BLM EPRS1 FBXO5 PIK3CB PRKDC PLEC MELK GCN1	3.64e-06	250	95	8	M11318
Coexpression	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN	PER2 CENPE JADE1 GFM1 MELK GCN1 TDP2	8.22e-06	199	95	7	M4977
Coexpression	WIERENGA_PML_INTERACTOME	PRKDC PLEC DNAH5 GCN1	1.63e-05	42	95	4	M2219
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	BLM IGSF10 RASGRP1 FBXO5 CENPE MELK	4.76e-06	200	96	6	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	BLM IGSF10 RASGRP1 FBXO5 CENPE MELK	4.76e-06	200	96	6	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BLM NBAS RASGRP1 MAGEB10 TRMT13	2.09e-05	154	96	5	ec920cae12ea1d14b6c973f6e903f895f80e3c50
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BLM FBXO5 RPS6KA5 CENPE MELK	3.36e-05	170	96	5	b04e2f84024baaae9b4ff19bdac8c69afdb92a76
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BLM FBXO5 RPS6KA5 CENPE MELK	3.65e-05	173	96	5	31784679190fbd95fc23d7c66008eb21b8c7cc5d
ToppCell	metastatic_Brain-Endothelial_cells-Stalk-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	NSUN3 PDSS1 KIAA0586 MAP3K9 ZFHX2	3.86e-05	175	96	5	f6a6db992e803d36c866a91706b02f67e0fd3e09
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBXO5 CENPE DUSP8 MELK NOTCH3	3.97e-05	176	96	5	45c6983ab671b0f306e7390320bd84f848e474cc
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYT1L FBXO5 CENPE SHE MELK	3.97e-05	176	96	5	8385435074cc5235b7af7424974f609388fc2cff
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZNF605 CENPE MCF2L2 FKBPL F5	4.19e-05	178	96	5	8b939659f713eea50a1a6e28b571f680ca0b4c12
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BLM RASGRP1 FBXO5 CENPE MELK	4.77e-05	183	96	5	29b62dd542bc3f8df843998f577724f3818d4271
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	NPC1 NBAS EPRS1 PRKDC ZNF292	5.03e-05	185	96	5	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	FBXO5 CENPE MELK GCN1 ZNF71	5.16e-05	186	96	5	799903b68bc6f6205d004b44c603424b0d5f7c32
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	NPC1 NBAS EPRS1 PRKDC ZNF292	5.16e-05	186	96	5	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RASGRP1 GLG1 ZZEF1 F5 GCN1	5.29e-05	187	96	5	4527d6426f2c4397e47f12439a13a8c14fd2aab2
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPE PDSS1 AS3MT KCNQ1 MELK	5.56e-05	189	96	5	45b9d00a4968fb22207d95228cdcf022afe1e50b
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPE PDSS1 AS3MT KCNQ1 MELK	5.56e-05	189	96	5	8382d331e01e83591ba9c8ea83edbf2436c18b17
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GLG1 ANKRD11 ROBO2 SNRK JADE1	5.70e-05	190	96	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BLM RASGRP1 FBXO5 CENPE MELK	5.85e-05	191	96	5	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO5 CENPE KLRG2 ERN2 MELK	5.85e-05	191	96	5	c8b99bd3a30c81ee4deba9cbf0196920ab3ab550
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FBXO5 CENPE KIAA0586 JADE1 MELK	5.85e-05	191	96	5	0ba5b112a82e489f5a21966f78a403a7436ce73b
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	NPC1 EPRS1 PIK3CB MRPL44 GFM1	5.99e-05	192	96	5	4e689bca7a242f8482e25f273656e2caba8821c0
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFAP126 PER2 PIK3CB CBARP	6.03e-05	98	96	4	95162072f3afc95e46f29db3d79ebd930bc09726
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBXO5 CENPE ROBO2 JADE1 MELK	6.14e-05	193	96	5	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L RASGRP1 ROBO2 CBARP KCNH3	6.14e-05	193	96	5	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L RASGRP1 ROBO2 CBARP KCNH3	6.14e-05	193	96	5	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RPS6KA5 ATAD2B MCF2L2 USP9Y ZNF292	6.14e-05	193	96	5	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L RASGRP1 ROBO2 CBARP KCNH3	6.45e-05	195	96	5	ffbab350e67d9c4b66c0ab84550daec8b8139a27
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD11 ROBO2 TSHZ1 SEC31A MADD	6.45e-05	195	96	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD11 ROBO2 TSHZ1 SEC31A MADD	6.45e-05	195	96	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IGSF10 FBXO5 CENPE ROBO2 TSHZ1	6.93e-05	198	96	5	148f5fee19ea8dff7f2de4ca69c3b03e5221985d
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NPC1 ATAD2B ANKRD11 USP9Y ZNF292	7.10e-05	199	96	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	RASGRP1 FEZF2 ADNP2 JADE1 NOTCH3	7.10e-05	199	96	5	358c4b3037f59378db8916a2fbe9ed4830cf1449
Drug	prednimustine	NPC1 BLM PLXNA1	3.64e-06	8	93	3	CID000034457
Disease	Mesenteric Venous Thrombosis	F2 F5	8.79e-06	2	88	2	C0267412
Disease	Mesenteric vascular insufficiency	F2 F5	8.79e-06	2	88	2	C1412000
Disease	Occlusive Mesenteric Arterial Ischemia	F2 F5	8.79e-06	2	88	2	C3852985
Disease	Acute Mesenteric Arterial Embolus	F2 F5	8.79e-06	2	88	2	C3852984
Disease	Acute Mesenteric Arterial Thrombosis	F2 F5	8.79e-06	2	88	2	C3852987
Disease	Nonocclusive Mesenteric Ischemia	F2 F5	8.79e-06	2	88	2	C3852986
Disease	mean fractional anisotropy measurement	DACT1 DUSP8 ANKRD11 PLEC ZZEF1	9.87e-06	95	88	5	EFO_0008399
Disease	Immunologic Deficiency Syndromes	BLM NBAS RASGRP1	4.35e-05	23	88	3	C0021051
Disease	STROKE, ISCHEMIC	F2 F5	8.74e-05	5	88	2	601367
Disease	Ischemic stroke	F2 F5	8.74e-05	5	88	2	cv:C0948008
Disease	pulmonary embolism (is_implicated_in)	F2 F5	8.74e-05	5	88	2	DOID:9477 (is_implicated_in)
Disease	retinal vein occlusion (is_implicated_in)	F2 F5	1.83e-04	7	88	2	DOID:1727 (is_implicated_in)
Disease	Combined oxidative phosphorylation deficiency	MRPL44 GFM1 TUFM	1.85e-04	37	88	3	cv:C4540031
Disease	blood cobalt measurement	KCNQ1 ROBO2 F5 NLRP3	2.42e-04	101	88	4	EFO_0007577
Disease	Venous Thromboembolism	F2 F5	2.43e-04	8	88	2	C1861172
Disease	Thrombophilia due to thrombin defect	F2 F5	2.43e-04	8	88	2	cv:C3160733
Disease	thrombosis (implicated_via_orthology)	PIK3CB F2	3.90e-04	10	88	2	DOID:0060903 (implicated_via_orthology)
Disease	osteonecrosis (is_implicated_in)	F2 F5	3.90e-04	10	88	2	DOID:10159 (is_implicated_in)
Disease	Posterior Choroidal Artery Infarction	F2 F5	4.75e-04	11	88	2	C0887799
Disease	Cerebral Infarction, Left Hemisphere	F2 F5	4.75e-04	11	88	2	C0751010
Disease	Anterior Choroidal Artery Infarction	F2 F5	4.75e-04	11	88	2	C0751012
Disease	Cerebral Infarction, Right Hemisphere	F2 F5	4.75e-04	11	88	2	C0751011
Disease	Subcortical Infarction	F2 F5	4.75e-04	11	88	2	C0751014
Disease	Cerebral Infarction	F2 F5	4.75e-04	11	88	2	C0007785
Disease	susceptibility to bacterial meningitis measurement	NSUN3 KCNQ1 DNAH5	5.10e-04	52	88	3	EFO_0008411
Disease	Thromboembolism	F2 F5	5.69e-04	12	88	2	C0040038
Disease	Cerebrovascular accident	F2 F5 NOTCH3	8.54e-04	62	88	3	C0038454
Disease	thrombosis (is_implicated_in)	F2 F5	9.00e-04	15	88	2	DOID:0060903 (is_implicated_in)
Disease	Blood Coagulation Disorders	F2 F5	1.03e-03	16	88	2	C0005779
Disease	Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism	F2 F5	1.16e-03	17	88	2	EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140
Disease	wellbeing measurement, alcohol consumption measurement	DACT1 KIAA0586 CMYA5	1.43e-03	74	88	3	EFO_0007869, EFO_0007878
Disease	colorectal adenoma (is_marker_for)	SEPHS2 F5	1.61e-03	20	88	2	DOID:0050860 (is_marker_for)
Disease	sexual dimorphism measurement	NPC1 SPG7 ATAD2B SF3A3 ANKRD11 KCNQ1 PLEC ZZEF1 GCN1 MADD	1.68e-03	1106	88	10	EFO_0021796
Disease	Deep Vein Thrombosis	F2 F5	1.78e-03	21	88	2	C0149871
Disease	prothrombin time measurement	F2 F5	1.78e-03	21	88	2	EFO_0008390
Disease	Venous Thrombosis	F2 F5	1.78e-03	21	88	2	C0042487
Disease	Myasthenic Syndromes, Congenital	PLEC CHRNG	2.33e-03	24	88	2	C0751882
Disease	Attention deficit hyperactivity disorder	AS3MT ZNF292	2.33e-03	24	88	2	C1263846
Disease	pre-eclampsia (is_implicated_in)	F2 F5	2.52e-03	25	88	2	DOID:10591 (is_implicated_in)
Disease	Varicose veins	GLG1 DUSP8 APEX1 CMYA5	2.70e-03	193	88	4	HP_0002619
Disease	Neurodevelopmental Disorders	MYT1L ANKRD11 ZNF292	2.74e-03	93	88	3	C1535926
Disease	alcohol use disorder (implicated_via_orthology)	PIK3CB NOTCH3 MADD CHRNG	2.80e-03	195	88	4	DOID:1574 (implicated_via_orthology)
Disease	corpus callosum mid-anterior volume measurement	DUSP8 PLEC	2.94e-03	27	88	2	EFO_0010297

Protein segments in the cluster

Peptide	Gene	Start	Entry
GLCVLPSGSVLDKLA	CBARP	656	Q8N350
LGSSGCLKGSPLVLK	ANKRD11	496	Q6UB99
CLKGSPLVLKDPSLF	ANKRD11	501	Q6UB99
KLCKLDSPSGAALGL	DUSP8	421	Q13202
AALEKLEKGPELGLS	CHRNG	411	P07510
KDLLPDLGEGFILAC	ASCC2	476	Q9H1I8
KDALAKNSPGLCLKI	RASGRP1	111	O95267
DCGTKLPGLLKREQS	ABCF3	101	Q9NUQ8
LKGLASRKPLVLCGD	APEX1	196	P27695
IGLDSCKELLKDLKG	ADNP2	26	Q6IQ32
CKELLKDLKGFDPGE	ADNP2	31	Q6IQ32
SGLLDIFKSKIGCPL	RAB3GAP1	206	Q15042
KNKCGLTPLLLGVHE	POTEB2	231	H3BUK9
LAILGKGDLIGCELP	KCNH3	636	Q9ULD8
LKLIDFGLCAKPKGN	MELK	146	Q14680
LDLCAAPGGKSIALL	NSUN3	136	Q9H649
GSAGLAKKCPFSLEL	KCNQ1	26	P51787
DCCSERLLGKKLGIP	MADD	201	Q8WXG6
ICDGKNPGRCKELLL	MOV10L1	416	Q9BXT6
LGCDAKLSDETGVPK	MAGEB10	186	Q96LZ2
LLGLTGNHLKCLPKE	LRRIQ4	146	A6NIV6
PKLSDAFLGELAEKC	ATAD2B	591	Q9ULI0
CKPGAGLLLVETLLD	ASMTL	546	O95671
VVLSDFGLCKKLPAG	ERN2	656	Q76MJ5
CPDDIGKLGKLLLHG	MCF2L2	831	Q86YR7
CGLSQEKEPFKKLGL	PER2	711	O15055
GKLSLPWLLNKELGC	PLXNA1	381	Q9UIW2
PVKICDFDLGSGIKL	MKNK2	221	Q9HBH9
GKKLTLACPGPLADS	NOTCH3	2081	Q9UM47
DLPEGAVKGLCKLFC	GCN1	41	Q92616
DLKDKPLGEGSFSIC	RPS6KA5	426	O75582
LCALEGRDPELGLKS	TUFM	221	P49411
EKILDLCAAPGGKTT	NSUN6	236	Q8TEA1
GGFLSLECEIKLAPK	NBAS	441	A2RRP1
ESKNKCGLTPLLLGV	POTEB3	266	A0JP26
PSSNDKALGLLCGKD	NPC1	166	O15118
ADAGTKKLECTLPDG	NID2	1291	Q14112
LDPALQDKCLIDLGK	GLG1	631	Q92896
DKPKLGSCCRVLALG	FKBPL	116	Q9UIM3
GDKLLLNCSATGEPK	IGSF10	1956	Q6WRI0
CKELGLEKEDAALLP	KLRG2	221	A4D1S0
IPDDKLKLLDCGNEL	BLM	386	P54132
GCPKSADLIGLLEYK	DACT1	206	Q9NYF0
DGKLLKASCKIGPLP	FBXO5	421	Q9UKT4
KLCTLEGLPLSAGKE	DCDC2B	176	A2VCK2
DLKLGLATGPVLFAC	PDSS1	326	Q5T2R2
FALEKPGKCTLHLGI	CMYA5	4046	Q8N3K9
EKLPTSGGCSALELK	AS3MT	326	Q9HBK9
DLLKASNGLCPEILG	CFAP126	101	Q5VTH2
LIPCKEAGLKFATGD	MPP1	176	Q00013
VEKGFLDACEKGPLS	GFM1	586	Q96RP9
LDACEKGPLSGHKLS	GFM1	591	Q96RP9
KETCLDLAGNPGILL	EFCAB3	126	Q8N7B9
LLDCTKKSGLFGLPP	PWWP2B	36	Q6NUJ5
GKVPKDLLCNLELEG	CENPE	706	Q02224
GFDLLEAGKCQLLPL	MAP3K9	766	P80192
LTLIKGGASLDLKAC	DNAH5	3916	Q8TE73
PGLGKSALIAALCDK	IRGQ	16	Q8WZA9
DGSQGKKLLNLCSPL	FEZF2	56	Q8TBJ5
ESKNKCGLTPLLLGV	POTEC	266	B2RU33
DKGIKLLCEGLLHPD	NLRP3	926	Q96P20
ESKNKCGLTPLLLGV	POTED	266	Q86YR6
CDKKLIAEGPGETVL	MRPL44	276	Q9H9J2
GADCLPGLLSVEEKK	TRMT13	411	Q9NUP7
LGDPCLKDLKKGDII	EPRS1	656	P07814
GPLLICQKGILHKDS	F5	1746	P12259
ALHSEGKLPKGCSVL	PIGL	166	Q9Y2B2
SKEIPKGAENCLEGL	RFC1	396	P35251
KNKCGLTPLLLGVHE	POTEB	231	A0A0A6YYL3
KEAEKSPQLGLGCLS	WRAP73	276	Q9P2S5
KCKLAGLEVLSDDPD	TDRD7	576	Q8NHU6
SEGKTLLKQPDLCGR	JADE1	606	Q6IE81
CDPGEKLDSKIGVLI	PIK3CB	116	P42338
PGCGKTLLAKAVATE	SPG7	351	Q9UQ90
GLCDSAKKDDLPELA	SNRK	406	Q9NRH2
PLAPAACISKIAKAG	LINC00615	56	Q96LM1
GCKVPQEALLKLLAG	SEPHS2	61	Q99611
GDEGCKALISFLEPK	ZFHX2	281	Q9C0A1
LGKSLIKFCSGDLGP	SLC27A1	196	Q6PCB7
CSEAELGAGLPLRLK	SPATA20	621	Q8TB22
PRSLDLLGLEKLDCG	TDP2	331	O95551
LLGLEKLDCGRFPSD	TDP2	336	O95551
LAKLCSDHPEIGIKG	ZNF292	211	O60281
VDGTALLKCKATGDP	ROBO2	431	Q9HCK4
VCLDHAKLGEGKLSP	USP9Y	1061	O00507
LCLLPLTDKAAKGGE	PLEC	3016	Q15149
KLPVLAGCLKGLSSL	PRKDC	216	P78527
LDPAKKLLLTASGDG	WDR55	176	Q9H6Y2
LTELLKKLCSGPEGG	ZZEF1	1061	O43149
KKLCSGPEGGLRKLD	ZZEF1	1066	O43149
SGEADCGLRPLFEKK	F2	331	P00734
DRLKSALLALGLKCG	SF3A3	261	Q12874
SPNLSKCGEELGRLK	PSMD8	106	P48556
ADPELLLSCGKDAKI	SEC31A	271	O94979
CEPADGGLKSETLAK	SHE	261	Q5VZ18
KLLGGSVPACHELKA	ZNF71	66	Q9NQZ8
GTGEKSLKCPFDLLI	ZNF605	96	Q86T29
AGKILKDPDSLAQCG	UBQLN3	66	Q9H347
LDDSPKGGLDILKSL	TSHZ1	541	Q6ZSZ6
EGEILFSCGQKLAPK	KIAA0586	1231	Q9BVV6
LSGCPIAAAEKLAKA	MYT1L	571	Q9UL68
KKDLITLSGCPLADK	MYT1L	876	Q9UL68